Construction method and application of genetic engineering strain of high-yield echinocandin B

Through the combined high expression of ecdA and htyF genes, a genetically engineered strain with high yield of echinocin B was constructed, which solved the problems of low fermentation yield and high production cost of echinocin B in the prior art, and achieved significant improvement of echinocin B The effect of yield of B has industrial application potential.

CN118909798APending Publication Date: 2024-11-08NANJING NORMAL UNIVERSITY
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410967005.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-18
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art has bottlenecks in improving the fermentation yield of echinocin B, including high viscosity of fermentation broth, insufficient oxygen supply, and limitation of raw materials. The randomness and uncertainty of obtaining high-yield strains through mutagenesis lead to huge screening work. , inefficient and fail to effectively reduce production costs.

Method used

Through the combined high expression of ecdA and htyF genes, the original promoter of ecdA is replaced as a constitutive strong promoter, and combined with htyF high-profile plasmid to transfer it into the strain, construct a genetically engineered strain with high yield of echinocin B to strengthen echinocin B synthesis The way to significantly increase the yield.

Benefits of technology

The fermentation yield of echinocin B was significantly improved. The yield of the chassis strain reached 366.5 mg/L after 48h seed culture and 108h fermentation culture, which was 110% higher than the original strain, and has potential industrial application value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909798A_ABST
    Figure CN118909798A_ABST
Patent Text Reader

Abstract

The invention discloses a construction method and application of a genetic engineering strain for high-yield echinocandin B. The engineering strain is obtained by high expression of an echinocandin A gene and / or an echinocandin B gene in a chassis bacterium which is aspergillus crassispinus. The invention provides a genetic engineering strain for high-yield echinocandin B. The fermentation yield of echinocandin B is increased by utilizing combined high expression of ecdA and htyF, and an ecdA original promoter in an original strain is replaced by a constitutive strong promoter gpdA by applying a molecular biology method, so that an ecdA high-expression engineering strain is obtained; the high expression of the htyF is realized on the engineering strain, so that the engineering strain with common high expression of the ecdA and the htyF is obtained. According to the engineering strain constructed by the invention, the synthetic route of the echinocandin B is enhanced, the yield of the echinocandin B of Aspergillus paclitus is remarkably increased, and the engineering strain has potential industrial application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and specifically relates to a method for constructing a genetic engineering strain with high yield of echinocandin B and application thereof. Background Art

[0002] Echinocandin B is a natural secondary metabolite produced by Aspergillus strains. It is the semi-synthetic precursor of the clinical first-line antifungal drug anidulafungin. Due to its excellent performance in clinical treatment, anidulafungin stands out from many antifungal drugs. However, its semi-synthetic precursor, echinocandin B, can only be produced by microbial fermentation and cannot be produced by chemical synthesis. Compared with chemical synthesis, biological fermentation has a longer cycle, a more complicated process, and a lower yield. Therefore, it is very important to increase the yield of echinocandin B or reduce production costs.

[0003] The strategies currently used to increase the fermentation yield of echinocandin B include obtaining high-yield strains by optimizing fermentation culture conditions and combining non-directed mutagenesis. There are also studies on improving fermentation yields by modifying metabolic pathways based on the genetic background of production strains. Improving fermentation yields by optimizing culture media is a strategy that is currently used more frequently because it does not require the establishment of a genetic manipulation system, is easy to operate, and can achieve the purpose of increasing yields in a shorter period of time. At the same time, since different strains have different requirements for nutrients during fermentation, after obtaining the modified strains, it is usually necessary to optimize the culture conditions to find the most suitable conditions for fermentation production of the strains; in the process of production and synthesis using bioreactors, the external nutritional environment (carbon source, nitrogen source and amino acid) and physical and chemical factors (temperature, light and pH, etc.) can affect the fermentation process. However, in the process of industrial production fermentation, simply changing the fermentation conditions often encounters many difficult problems that are difficult to overcome, such as high viscosity of the fermentation broth, insufficient oxygen supply, and raw material limitations, which are easy to lead to breakthroughs and bottlenecks in improving fermentation yields. In addition, obtaining high-yield strains through mutagenesis has the disadvantages of randomness and uncertainty, resulting in huge screening workload and low efficiency. Therefore, it is currently a preferred technology in synthetic biology to perform genetic editing operations on production strains through targeted modification of target genes, construct engineered strains according to the expected biosynthetic process, and edit the corresponding target genes so that the microorganisms have specific traits that are beneficial to production and fermentation.

[0004] Aspergillus pachycristatus NRRL 11440 is an industrial strain used to produce echinocandin B, so there has been a certain accumulation of research on its genetic background and the regulatory mechanism of echinocandin B biosynthesis. However, the accumulation of byproducts and the uncertainty of mutagenesis results caused by the optimization of fermentation culture conditions and the strategy of obtaining high-yield strains through mutagenesis breeding have greatly increased the cost of subsequent product processing and high-yield strain screening. Therefore, the low fermentation yield of this strain has led to high production costs of echinocandin B antifungal drugs. In addition to this strain, some strains in the genus Aspergillus have been isolated, which can also ferment and produce echinocandin B fermentation products. Since the synthetic gene cluster of echinocandin B has not been clearly resolved, most of the current research on improving the fermentation yield of echinocandin B focuses on the optimization of fermentation culture conditions. At the same time, people have also obtained randomly mutated strains through mutagenesis breeding to increase the yield to a certain extent. However, there are few reports on the targeted high-profile or editing of target genes. Therefore, finding a gene editing method to improve echinocandin B and construct a high-yield strain has important scientific value and potential application. Summary of the invention

[0005] Purpose of the invention: In view of the problems existing in the prior art, the present invention provides a genetically engineered strain with high yield of echinocandin B. The present invention utilizes the combined high expression of ecdA and htyF to improve the fermentation yield of echinocandin B. The original promoter of ecdA in the original strain is replaced with the constitutive strong promoter gpdA by molecular biological methods to obtain an ecdA high-expression engineered strain; htyF is highly expressed on this engineered strain to obtain an ecdA and htyF co-high-expression engineered strain. The engineered strains constructed by the present invention all strengthen the echinocandin B synthesis pathway, significantly improve the echinocandin B yield of strains with echinocandin gene clusters, and have potential industrial application value.

[0006] The invention also provides a construction method and application of the genetic engineering strain.

[0007] Technical solution: In order to achieve the above-mentioned purpose, the present invention discloses a genetically engineered strain with high production of echinocandin B. The engineered strain is obtained by using a strain having a gene cluster for producing echinocandin as a base strain and highly expressing the ecdA gene and / or the htyF gene in the base strain.

[0008] The sequences of the ecdA gene and the htyF gene are JX421684.1 (41269-63178) and JX421685.1 (22453-25202), respectively.

[0009] Wherein, the strain having the gene cluster for producing echinocandins includes Aspergillus pachycristatus. Preferably, the Aspergillus pachycristatus is Aspergillus pachycristatus NRRL 11440 (CPCC400818).

[0010] The method for constructing a genetically engineered strain with high production of echinocandin B of the present invention comprises the following steps:

[0011] (1) Designing primers based on the ecdA gene sequence, using the genomic DNA of the chassis bacteria as a template, and amplifying the left and right homologous arms by PCR; fusing the left and right arms with a fragment containing the gpdA promoter, and introducing the fusion into the protoplasts of the chassis bacteria to obtain strain LP-1;

[0012] (2) Primers were designed based on the htyF gene sequence, and the genomic DNA of the chassis bacteria was used as a template to obtain the htyF gene by PCR amplification. After ligation with the vector, a high-expression htyF plasmid was obtained, which was then transferred into the protoplasts of strain LP-1 to obtain strain LP-2.

[0013] Wherein, the primer sequences described in step (1) include ecdA-LF / ecdA-LR (SEQ ID NO.1-2) and ecdA-RF / ecdA-RR (SEQ ID NO.3-4):

[0014] ecdA-LF TGTACTGTCTGTAGCGAGCA

[0015] ecdA-LR TAATCAATTGCCCGTCTGTCAAGGTCATTCAAGAGTGAAACecdA-RF CATCCAAGAACCTTTAATCAATGGAACGGAAACGCGTATT

[0016] ecdA-RR AGGATATTGGCCTGGAACTG.

[0017] Wherein, in step (1), the native promoter of the gene is replaced with a constitutive strong promoter by homologous recombination, and the constitutive strong promoter is the gpdA (3-phosphoglyceraldehyde dehydrogenase) promoter.

[0018] Wherein, the primer sequences described in step (2) include OE-htyF, EcoRⅤ-F and OE-htyF, EcoRⅤ-R (SEQID NO.5-6):

[0019] OE-htyF,EcoRⅤ-F:

[0020] GGCTGCAGGAATTCGATATCATGCTCGCTACAGACAGTAC

[0021] OE-htyF,EcoRⅤ-R:

[0022] GTATCGATAAGCTTGATATCCTAATTCTTTGTGGCCGATG.

[0023] Wherein, the vector described in step (2) is a pBARGPE1-Hygro plasmid, and the htyF high-profile plasmid comprises a constitutive strong promoter gpdA, an htyF gene, a terminator trpC and a resistance screening marker.

[0024] Furthermore, in step (2), the high expression of htyF is achieved by randomly transferring the htyF high-modulation plasmid to increase the gene copy number; the biological function of htyF is to oxidatively modify the echinocandin B precursor NNU-1 into echinocandin B. The echinocandin B precursor NNU-1 has a nucleocytoplasmic ratio of 1044.3 [M+H] + and a retention time of 26.5 to 27.5 min under the LC-MS detection conditions of the present invention.

[0025] The invention relates to the use of the genetically engineered strain with high yield of echinocandin B in the production of echinocandin B.

[0026] The invention discloses an application of the ecdA gene and / or htyF gene in regulating the production of echinocandin B in a strain having an echinocandin gene cluster.

[0027] The construction method and application of the present invention for using ecdA and htyF to jointly enhance the production of echinocandin B are applicable to all species that can synthesize echinocandin B and contain the echinocandin B biosynthesis gene cluster.

[0028] The present invention proposes a strain that combines and highly expresses a gene cluster capable of producing echinocandins, such as Aspergillus pachycristatus, non-ribosomal peptide synthetase EcdA and amino acid hydroxylase HtyF, which can enhance the production of echinocandin B (ECB) and improve the fermentation yield of ECB. The present invention uses Aspergillus pachycristatus as the base strain, and first analyzes and identifies the involvement of HtyF in the oxidative modification process in the biosynthesis of echinocandin B through gene knockout and backfilling. When htyF in Aspergillus pachycristatus is knocked out, HPLC analysis finds that the peak time is different from that of standard ECB, and LC-MS analysis finds that the product is non-hydroxylated ECB. Further backfilling and analysis confirm that HtyF is responsible for converting the echinocandin B precursor into echinocandin B through oxidative modification. Subsequently, by highly expressing the non-ribosomal peptide synthetase encoding gene ecdA in the echinocandin B biosynthetic gene cluster, it was found that not only can the production of echinocandin B be significantly improved, but also another product peak can be accumulated. The product is the same precursor after the deletion of htyF, that is, non-hydroxylated ECB. Therefore, it is speculated that by synchronously highly expressing ecdA and htyF, not only the synthesis of the precursor-non-ribosomal hexapeptide constituting echinocandin B is promoted, but also its oxidative modification can also increase the production of ECB. Finally, by constructing a strain of EcdA and HtyF of Aspergillus thunbergii with synchronous high expression, the production of ECB was improved. HPLC analysis found that the high-expression strain only produced a single echinocandin B peak. Therefore, the present invention found that the synchronous high expression of non-ribosomal peptide synthetase EcdA and amino acid hydroxylase HtyF is the rate-limiting factor for the production of echinocandin B. The technology of combining high expression of ecdA and htyF in the present invention is speculated to be applied to other strains producing echinocandin B, and the present invention also provides a reference for the molecular regulation mechanism of echinocandin B fermentation.

[0029] Specifically, the present invention first proves the biological function of htyF in the biosynthesis of echinocandin B and identifies the characteristics of the substrate in the HtyF catalytic reaction. The specific steps include:

[0030] 1. Knock out the htyF gene in the genome of the chassis strain to obtain the htyF knockout strain LP-3.

[0031] 2. Introduce the htyF gene of the chassis strain into the genome of the knockout strain LP-3 to obtain the htyF complemented strain LP-4.

[0032] 3. The fermentation extracts obtained from the fermentation culture of strains LP-3, LP-4 and chassis strains were analyzed by HPLC, and it was found that a precursor of echinocandin B accumulated in the fermentation extract of strain LP-3, and it was named NNU-1.

[0033] 4. Analyze echinocandin B and NNU-1 using LC-MS to demonstrate the biological function of htyF in the biosynthesis of echinocandin B and identify the characteristics of compound NNU-1.

[0034] The construction of the knockout and complementation strains can be obtained by genetic engineering means, and the strain LP-3 is obtained by homologous recombination replacement, and the strain LP-4 is obtained by random integration of fragments.

[0035] Then, the present invention constructs a genetically engineered strain with high yield of echinocandin B, wherein the genetically engineered strain with high yield of echinocandin B uses Aspergillus pachycristatus NRRL 11440 as a chassis strain, and the construction method thereof comprises the following steps:

[0036] 1. Highly express the ecdA gene in the genome of the chassis bacteria to obtain the genetically engineered strain LP-1.

[0037] 2. Using the genetically engineered strain LP-1 as the base strain, the htyF gene in the base strain genome was highly expressed to obtain the genetically engineered strain LP-2.

[0038] In the biosynthesis process of echinocandin B, the synthesis of the hexapeptide core of echinocandin B is carried out with the participation of a non-ribosomal peptide synthetase (NRPS) encoded by ecdA, which contains six component modules and can synthesize the hexapeptide core structure of echinocandin B through condensation, adenylation and thiolation with the participation of six amino acids, and then synthesize the echinocandin B precursor with the participation of a series of genes. Then, the echinocandin B precursor is oxidatively modified under the action of an oxidase encoded by htyF, and finally converted into echinocandin B. The present invention uses Aspergillus pachycristatus NRRL 11440 as a chassis strain, and through the ecdA gene in the genome of the highly expressed chassis bacteria and the htyF gene in the genome of the highly expressed chassis bacteria, the metabolic flow of the echinocandin B biosynthesis process can be strengthened, so that the genetically engineered strain obtained by the transformation can efficiently produce echinocandin B.

[0039] In fact, there is currently no report proving that high-regulation ecdA can definitely increase the fermentation yield of echinocandin B, and some genes in the high-regulation echinocandin B biosynthesis gene cluster have not achieved the effect of increasing the fermentation yield of echinocandin B. The present invention found in preliminary studies that the echinocandin B yield of the single high-regulation strain LP-5 of htyF was not increased.

[0040] The present invention proves that htyF is involved in the biosynthesis of echinocandin B, but its high-tuning cannot increase the fermentation yield of echinocandin B. This also shows that not all high-tuning genes involved in the synthesis of echinocandin B can increase the yield, and it may also indicate that the method of high-tuning ecdA is not necessarily a result to increase the yield of echinocandin B. The present invention found that the yields of echinocandin B and NNU-1 of the ecdA high-tuning strain LP-1 were significantly increased relative to the chassis strain. Further, the present invention found that the high-tuning of ecdA alone and htyF alone, which did not work, and the high-tuning strain LP-2 together can further significantly increase the yield of echinocandin B, and significantly exceed the high-tuning strain LP-1 and the chassis strain alone, proving that the high-tuning of ecdA and htyF together has a synergistic effect on the fermentation yield of echinocandin B.

[0041] Specifically, the present invention uses Aspergillus pachycristatus NRRL 11440 as a base strain, (1) highly expresses the ecdA gene in the base strain genome to obtain a genetically engineered bacterium LP-1, promotes the initial process of echinocandin B synthesis, and strengthens the synthesis and accumulation of echinocandin B and its precursors. (2) highly expresses the htyF gene in the base strain genome to obtain a genetically engineered bacterium LP-2, promotes the oxidation modification and transformation of echinocandin B precursors, further increases the biosynthesis of echinocandin B, and finally obtains a genetically engineered strain with high yield of echinocandin B.

[0042] At the same time, the present invention provides a method for constructing the above-mentioned high-yield echinocandin B genetic engineering strain, comprising the following steps:

[0043] Step S1: Using Aspergillus pachycristatus NRRL 11440 as the base bacteria, the ecdA gene in the base bacteria genome is highly expressed to obtain the genetically engineered bacteria LP-1.

[0044] Step S2: highly expressing the htyF gene in the genome of the genetically engineered bacterium LP-1 to obtain the genetically engineered bacterium LP-2.

[0045] The construction of the above-mentioned high-yield echinocandin B genetically engineered strain can be obtained by genetic engineering means. The native promoter of the gene is replaced with a constitutive strong promoter by homologous recombination to obtain the genetically engineered strain LP-1, and the genetically engineered strain LP-2 is obtained by randomly transferring a high-modulation plasmid to increase the gene copy number.

[0046] The present invention uses Aspergillus pachycristatus NRRL 11440 as a chassis strain, and transforms the chassis strain through steps S1 and S2 to strengthen the metabolic flow of the biosynthesis process of echinocandin B and increase the yield of echinocandin B. The present invention first promotes the initial process of echinocandin B synthesis by highly expressing the ecdA gene in the genome of the chassis bacteria, and strengthens the synthesis and accumulation of echinocandin B and its precursor NNU-1. Then, by highly expressing the htyF gene in the genome of the chassis bacteria, the oxidative modification and conversion of the echinocandin B precursor is promoted, the biosynthesis of echinocandin B is further increased, and finally a genetically engineered strain with high yield of echinocandin B is obtained.

[0047] Beneficial effects: Compared with the prior art, the present invention has the following advantages:

[0048] The present invention uses Aspergillus pachycristatus NRRL 11440 as a chassis strain, and strengthens the metabolic flow of the biosynthesis process of echinocandin B by transforming the metabolic pathway in the chassis strain. First, the ecdA gene in the chassis bacteria genome is highly expressed to promote the initial process of echinocandin B synthesis, and strengthen the synthesis and accumulation of echinocandin B and its precursor NNU-1. Then the htyF gene in the chassis bacteria genome is highly expressed to promote the oxidation modification and conversion of echinocandin B precursors, further increase the biosynthesis of echinocandin B, and finally obtain a genetically engineered strain with high yield of echinocandin B. The construction of the genetically engineered strain significantly improves the fermentation yield of echinocandin B. When the chassis strain is cultured in a liquid shake flask, after 48h seed culture and 108h fermentation culture, the fermentation yield of echinocandin B is 174.5mg / L. When the genetically engineered strain LP-2 provided by the present invention is cultured in a liquid shake flask, after 48h of seed culture and 108h of fermentation culture, the fermentation yield of echinocandin B is 366.5mg / L, the yield is significantly improved, and the strain has potential industrial application value. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] Figure 1 HPLC (left) and LC-MS (right) analysis results of NNU-1 in the fermentation extract of strain LP-3 and the echinocandin B standard of the present invention.

[0050] Figure 2 This is a schematic diagram of the genetically engineered strain LP-1 obtained by high expression of ecdA according to the present invention.

[0051] Figure 3 This is the htyF high-modulation plasmid used in the construction process of the genetically engineered strain LP-2 described in the present invention.

[0052] Figure 4The results are a comparison of the echinocandin B production between the genetically engineered strain LP-2 constructed in the present invention and the chassis strain (wherein * represents p < 0.05, ** represents p < 0.01, and *** represents p < 0.005).

[0053] Figure 5 Comparison of the echinocandin B production between the genetically engineered strain LP-5 constructed in the present invention and the chassis strain (ns represents no significant difference). DETAILED DESCRIPTION

[0054] The present invention is further described below in conjunction with the accompanying drawings and embodiments.

[0055] Unless otherwise specified, the materials and reagents used in the examples of the present invention can be obtained from commercial sources. Experimental methods without specific conditions in the examples are usually carried out under conventional conditions or under conditions recommended by the manufacturer.

[0056] 1. The chassis strain used in the present invention is the wild-type Aspergillus pachycristatus NRRL11440, which is a general industrial strain for producing echinocandin B reported at home and abroad, and is reported in relevant literature. The strain Aspergillus pachycristatus NRRL 11440 used in the present invention is ATCC 58397, or Aspergillus pachycristatus NRRL 11440 provided by the National Microbial Resources Platform, China Pharmaceutical Microbiological Culture Collection Management Center, strain number CPCC400818, which is an internationally used wild-type Aspergillus pachycristatus NRRL 11440 strain. The wild-type Aspergillus pachycristatus NRRL 11440 strain obtained from any channel can be used in the present invention.

[0057] The genes ecdA and htyF involved in the construction of the genetically engineered strains of the present invention have gene IDs that are used to uniquely identify genes in the National Center for Biotechnology Information (NCBI) database of the United States, as shown in Table 1. Tables 2 and 3 are the strain names of the present invention and the primers designed and used, respectively.

[0058] Table 1 Genes involved in the construction of genetically engineered strains

[0059] Gene name Gene ID ecdA JX421684.1(41269-63178) F JX421685.1(22453-25202)

[0060] Table 2 Summary of strain information

[0061] Strain name genotype Aspergillus pachycristatusNRRL 11440 WT LP-1 ecdA::bleo-gpd-ecdA LP-2 ecdA::bleo-gpd-ecdA,Pgpd-htyF LP-3 ΔhtyF::hph LP-4 ΔhtyF::hph,htyF::bleo LP-5 WT, Pgpd-htyF

[0062] Table 3 Primer information summary

[0063]

[0064]

[0065]

[0066] 2. The process of analyzing the fermentation extract of each strain in the present invention includes seed culture, fermentation culture and obtaining the fermentation extract, and the specific steps are as follows:

[0067] ①Seed culture medium and seed culture process:

[0068] S1: The composition of the seed culture medium is as follows: 10 g glucose, 10 g glycerol, 25 g cottonseed cake powder, and 1 g calcium carbonate per 1 L of culture medium.

[0069] S2: The seed culture process is as follows: the strain constructed in the present invention is inoculated into the seed culture medium and cultured at 25° C. and 220 rpm for 48 h.

[0070] ② Fermentation medium and fermentation process:

[0071] S1: The composition of the seed culture medium is as follows: 20 g peanut oil, 8.6 g peptone, 40 g soybean cake powder, 2.44 g dipotassium hydrogen phosphate, 0.5 g calcium chloride, 0.5 g magnesium sulfate heptahydrate, 0.5 g ferrous sulfate heptahydrate, 0.2 g manganese sulfate monohydrate, 0.6 g copper sulfate pentahydrate, and sodium hydroxide to adjust the pH to 6.68 per 1 L of culture medium.

[0072] S2: The fermentation culture process is as follows: the bacterial liquid after seed culture is inoculated into the fermentation medium at a ratio of 1:10 (v:v) and cultured at 25°C and 220 rpm for 108 h.

[0073] ③ Obtaining the fermentation extract: The cultured fermentation culture was washed and filtered with single distilled water to remove the remaining culture medium components, the mycelium was collected, extracted with methanol, mixed and dispersed, and then placed in a constant temperature shaker at 16°C and 180rpm for 8 hours. The extracted mixture was filtered to obtain the fermentation extract.

[0074] 3. The molecular weight of the echinocandin B standard and NNU-1 in the embodiments of the present invention was detected and analyzed by LC-MS method, and the detection method was as follows:

[0075] ④Chromatographic conditions: AQ-C18 column (4.6×250 mm, Yuexu), mobile phase flow rate 0.6 mL / min, column temperature 40°C, detection wavelength 222 nm.

[0076] ⑤Sample processing: The obtained fermentation extract was filtered through a 0.22 μm organic nylon filter membrane.

[0077] ⑥ Preparation of Echinocandin B standard: Prepare the Echinocandin B standard with methanol as solvent to form a 2 mg / mL stock solution, then dilute it to a sample solution with a concentration of 150 μg / mL, and filter it through a 0.22 μm organic nylon filter membrane.

[0078] ⑦ Mobile phase: The mobile phase ratio used was methanol: acetonitrile: water = 7:1:2 (v / v), and each mobile phase was filtered using a 0.22 μm microporous filter membrane (organic phase and aqueous phase).

[0079] ⑧Data collection time: 45min.

[0080] 4. The yield of echinocandin B in the embodiment of the present invention was detected and analyzed by HPLC, and the detection method was as follows:

[0081] ①Chromatographic conditions: AQ-C18 column (4.6×250 mm, Yuexu), mobile phase flow rate 1.0 mL / min, column temperature 40°C, detection wavelength 222 nm.

[0082] ②Sample processing: The obtained fermentation extract was filtered through a 0.22 μm organic nylon filter membrane.

[0083] ③ Mobile phase: The mobile phase ratio used was methanol: acetonitrile: water = 7:1:2 (v / v), and each mobile phase was filtered using a 0.22 μm microporous filter membrane (organic phase and aqueous phase).

[0084] ④Data collection time: 25 minutes.

[0085] 5. The present invention proves the biological function of htyF in the biosynthesis of echinocandin B, identifies the characteristics of the substrate in the HtyF catalytic reaction, and provides a method for constructing a genetically engineered strain with high yield of echinocandin B. The specific process is as follows:

[0086] (1) htyF knockout strain A. pachycristatus (ΔhtyF::hph), denoted as LP-3; LP-3 was subjected to fermentation test, and NNU-1 in the fermentation extract was analyzed and characterized by LC-MS.

[0087] (2) Using A. pachycristatus NRRL 11440 as the chassis cell, the homologous recombination replacement technology was used to replace the native promoter of the ecdA gene in the chassis strain genome with the constitutive strong promoter gpd to obtain a genetically engineered strain (ecdA::bleo-gpd-ecdA), which was recorded as LP-1.

[0088] (3) Using random insertion technology, the htyF high-modulation plasmid was randomly transferred into the genome of the genetically engineered strain LP-1 to obtain the genetically engineered strain (ecdA::bleo-gpd-ecdA, Pgpd-htyF), which was recorded as LP-2.

[0089] 6. The preparation of protoplasts of the strain is carried out according to the conventional method, as follows:

[0090] (1) Bacterial cell extraction: The culture medium containing the logarithmic phase bacteria in the conical flask was transferred to a new 50 mL centrifuge tube and centrifuged at 8000 rpm for 8 min. After centrifugation, the liquid culture medium was discarded and the bacteria at the bottom were retained.

[0091] (2) Preparation of enzymatic solution (prepared and used immediately): Weigh 1 g of lyase (Novozymes DK-2880) and dissolve it completely in 10 mL of OM solution (10 mM phosphate buffer, 144.48 g / L magnesium sulfate, adjusted to pH 5.8 using disodium hydrogen phosphate) (2 M phosphate buffer: 163.4 g / L sodium dihydrogen phosphate, 90.9 g / L sodium dihydrogen phosphate, adjusted to pH 7.0); filter the prepared enzymatic solution using a 0.22 μm sterile filter and place it in a 50 mL conical flask.

[0092] (3) Enzymolysis: Add the bacterial cells obtained by culture and separation into a 50 mL conical flask containing the prepared enzymolysis solution, and thoroughly blow and beat to disperse the bacterial cells. Place the conical flask in a constant temperature shaker at 28°C and 80 rpm for enzymolysis. Take out the conical flask every hour for blowing and mixing, and take samples for microscopic examination of the state of the protoplasts. When the microscopic examination results show that only a small amount of hyphae exists in the field of view, and a large number of protoplasts are uniform in size and in a vacuolar state, take out the enzymolysis conical flask from the shaker.

[0093] (4) Protoplast separation: Transfer the enzymatic solution containing protoplasts from the conical flask to a new 50 mL centrifuge tube and place it on ice. Slowly add an equal volume of pre-cooled Trapping solution along the wall of the centrifuge tube. Buffer solution (109.3 g / L sorbitol, 12.11 g / L tris(hydroxymethyl)aminomethane, pH adjusted to 7.0 using hydrochloric acid), centrifugation, 4°C, 5000 rpm, 15 min, at this time the solution in the centrifuge tube is divided into three layers, protoplasts are present in the middle layer, carefully draw the protoplasts in the middle layer into a new 50 mL centrifuge tube, add 10 mL of precooled STC solution (218.6 g / L sorbitol, 1.11 g / L calcium chloride, 1.211 g / L tris(hydroxymethyl)aminomethane, pH adjusted to 7.5 using hydrochloric acid) to the centrifuge tube, centrifugation, 4°C, 6000 rpm, 10 min, at this time the protoplasts adhere to the wall, discard the liquid in the centrifuge tube, add about 2 mL of STC solution to resuspend the protoplasts at the bottom, and examine the prepared protoplasts under a microscope for the state and quantity of the protoplasts.

[0094] Example 1

[0095] Functional verification of htyF in the biosynthesis of echinocandin B and characterization of NNU-1

[0096] The chassis strain A. pachycristatus NRRL 11440 and the successfully constructed htyF knockout and complementation strains LP-3 and LP-4 were cultured using steps 2-4 in the above specific implementation method to obtain fermentation extracts. HPLC analysis results showed that htyF was involved in the conversion process between echinocandin B and NNU-1.

[0097] During the construction of each strain: the amplification PCR reaction system, the diagnostic PCR reaction system, the fusion PCR reaction program, and the PCR reaction program are shown in Tables 4-7 respectively.

[0098] Table 4 Amplification PCR reaction system

[0099]

[0100] Table 5 Diagnostic PCR reaction system

[0101]

[0102] Table 6 Fusion PCR reaction program

[0103]

[0104]

[0105] Table 7 PCR reaction program

[0106]

[0107] Construction of LP-3 strain: primers htyF-LF / htyF-L-hyg-R and htyF-R-hyg-F / htyF-RR were designed and used, and the chassis strain genomic DNA was used as a template using an amplification PCR system and reaction program to amplify the left and right homologous arms of each gene. The obtained left and right homologous arms were 1000bp gene sequences upstream of the start site ATG and downstream of the end site TAG / TAA of each gene, respectively. Among them, htyF-L-hyg-R and htyF-R-hyg-F respectively carried a sequence that could complement the start and end positions of the screening marker hph gene fragment, so that it could be connected to the screening marker gene sequence; the resistance screening marker hph gene fragment was obtained by PCR amplification using primers hyg-F / hyg-R and commercial plasmid pAN7-1 (P0302 Miaoling Biology) as a template. The left and right homologous arms of the amplified gene and the screening resistance gene fragment were recovered and their concentrations were determined respectively. The left homologous arm, hph screening marker, and right homologous arm were mixed in a molar ratio of 1:2:1 using primers htyF-yan-F / htyF-yan-R and used as templates for fusion PCR amplification. The three fragments were fused, and the fragment size was obtained by diagnostic PCR amplification and agarose gel electrophoresis analysis to obtain the linear donor knockout framework used for gene knockout. The constructed linear donor knockout framework was mixed with the protoplasts of the chassis strain and ice-bathed for 50 minutes. 10 μg of the linear donor knockout framework was added to every 100 μL of protoplasts, followed by 1.25 mL of PEG and placed at room temperature for 25 minutes (PEG: PEG 400060%, CaCl22.35 g / L, Tris-HCl 50 mM, pH adjusted to 7.5 with hydrochloric acid (HCl), sterilized at 115°C for 20 minutes). The correct colonies were screened on hygromycin resistance plates, and the resistant strains were cultured in rich culture medium and genomic DNA was extracted. The diagnostic PCR (using diagnostic primers htyF-LF / hyg-yan-R, hyg-yan-F / htyF-RR, htyF-qiao-F / htyF-qiao-R, respectively, was used to perform PCR diagnostic verification on the left arm, right arm and partial sequence of the gene ORF region (open reading frame) of the knockout transformed strain genome, and the primers were detailed in Table 3) for verification.

[0108] Construction of LP-4 strain: Using primers htyF-LF and htyF-R-bleo-R, WT strain genomic DNA as a template, PCR amplification was used to obtain the ORF region of the gene and 1000bp of the upstream and downstream gene sequences, the obtained sequence contained the gene and its original promoter and terminator, which enabled the gene to be normally expressed after being transferred into the host; the primer htyF-R-bleo-R used had a sequence that could complement the starting position of the screening marker gene bleo, so that it could be connected to the screening resistance gene sequence; the resistance screening marker bleo gene fragment was obtained by using primers bleo-F / bleo-R and a plasmid containing the bleo screening marker as a template by PCR amplification (the bleo screening marker gene fragment is such as SEQ ID NO.1 in Example 2, which can be synthesized by a biological company). The target gene sequence and the screening resistance gene fragment containing the original promoter and terminator obtained by amplification were recovered and the concentration was determined respectively. The target gene sequence and the bleo screening marker were mixed in a molar ratio of 1:1 using primers htyF-yan-F / bleo-R and used as templates for fusion PCR amplification. The two fragments were fused to obtain the linear complementation gene framework used for gene knockout. The constructed linear complementation gene framework was mixed with the protoplasts of the LP-3 strain and ice-bathed for 50 minutes, followed by adding 1.25 mL PEG and leaving at room temperature for 25 minutes. The correct colonies were screened by bleomycin resistance plates, and the resistant strains were cultured in rich medium and then genomic DNA was extracted and verified by diagnostic PCR (the diagnostic primers were htyF-hui-yan-F / htyF-hui-yan-R to verify the complementation transformation strain genome, and the primers were detailed in Table 3).

[0109] The fermentation extract of LP-3 was subjected to LC-MS analysis to identify the characteristics of NNU-1.

[0110] like Figure 1 As shown in the figure, under the LC-MS detection conditions of the present invention, the liquid phase peak time of NNU-1 is between 26.5 and 27.5 min, and the corresponding nucleus-mass ratio is M / Z=1044.3[M+H] + The liquid phase peak time of echinocandin B is between 24 and 25 min, and the corresponding nucleus-to-mass ratio is M / Z=1060.3[M+H] + The above experiments show that htyF is involved in the biosynthesis of echinocandin B and is related to the oxidative modification during the synthesis process. htyF is involved in the conversion of NNU to echinocandin B.

[0111] Embodiment 2,

[0112] Construction of the echinocandin B-producing strain LP-1

[0113] Since the full length of the ecdA gene in the echinocandin B biosynthesis gene cluster is greater than 2MB, the present invention replaces the original promoter of ecdA with a gpd constitutive strong promoter by constructing a donor replacement framework to achieve the purpose of high-regulating the gene.

[0114] ① The chassis strain A. pachycristatus NRRL 11440 was inoculated into rich culture medium (YG medium: 5 g / L yeast extract, 20 g / L glucose, 1 mL / L 1000× trace elements, including: 1000× trace elements: 22 g / L zinc sulfate heptahydrate, 11 g / L boric acid, 5 g / L manganese chloride tetrahydrate, 5 g / L ferrous sulfate heptahydrate, 1.6 g / L cobalt dichloride pentahydrate, 1.6 g / L copper sulfate, 1.1 g / L ammonium heptamolybdate tetrahydrate, 50 g / L EDTA, potassium hydroxide adjusted to pH 6.5) and cultured at 37°C, 220 rpm for 24 h, and the whole genome DNA was extracted using the Shenggong Fungal Genome Extraction Kit (B518229 Fungal Genomic DNA Rapid Extraction Kit). Escherichia coli containing the pBARGPE1-Hygro plasmid (P0381 Miaoling Biotechnology) was inoculated into liquid LB medium and cultured at 37°C and 220 rpm for 12 h. The pBARGPE1-Hygro plasmid was extracted using the Novezan plasmid extraction kit (DC201-01 FastPure PlasmidMini Kit).

[0115]

[0116] ③ Design and use primers ecdA-LF / ecdA-LR and ecdA-RF / ecdA-RR, use PCR to amplify the left and right homologous arms of the donor replacement framework using the genomic DNA of the chassis strain A.pachycristatus NRRL 11440 as a template (the PCR system and reaction procedure are the same as step ②), and the obtained left and right homologous arms are 1000bp of gene sequences upstream and downstream of the start site ATG of each gene. The left homologous arm, fusion fragment 1, and right homologous arm are mixed in a molar ratio of 1:2:1 as a template, and primers ecdA-merge-F / ecdA-merge-R are designed and used for fusion PCR amplification. The three fragments are fused to obtain the linear donor replacement framework used for promoter replacement (the fusion PCR system and reaction procedure are the same as step ②). The fusion fragment 2 after fusion is purified and recovered, and the concentration is measured.

[0117] ④ The constructed linear donor replacement framework was used to determine the size of the fusion fragment by agarose gel electrophoresis, and then introduced into the protoplasts of the chassis strain A. pachycristatus NRRL 11440. Specifically, the constructed fusion fragment 2 was mixed with the protoplasts of the chassis strain and ice-bathed for 50 minutes. 10 μg of fusion fragment 2 was added to each 100 μL of protoplasts, followed by 1.25 mL of PEG and placed at room temperature for 25 minutes) (PEG: PEG 4000 60%, calcium chloride 2.35 g / L, Tris-HCl 50 mM, hydrochloric acid was used to adjust the pH to 7.5, and sterilized at 115° C. for 20 minutes. The correct colonies were screened out by bleomycin resistance plates, and the resistant strains were cultured in rich culture medium and then genomic DNA was extracted. The diagnostic PCR was performed with the diagnostic primers gpd-yan-new-F / ecdA-merge-R primers, as shown in Table 3 for details.

[0118] ⑤ The strain LP-1 verified correct by diagnostic PCR was fermented and cultured using the fermentation method described above in the present invention, the bacteria after fermentation and culture were collected, and RNA was extracted using the Biotechnology Total RNA Extraction Kit (Product No. B511361 Column Total RNA Extraction Kit), and the expression level of ecdA of the LP-1 strain under fermentation and culture conditions was determined by qPCR (using primers RT-ecdA-F / RT-ecdA-R, as shown in Table 3 for primers).

[0119] ⑥ Such as Figure 2As shown, a band with a size of 1700 bp was verified in the genome of the successfully constructed LP-1 strain, and under the fermentation culture conditions of the present invention, the expression level of ecdA in the LP-1 strain was significantly higher than that of the chassis strain under the same conditions.

[0120] Example 3

[0121] Construction of high-profile htyF plasmid

[0122] ① Obtaining the htyF gene: Design and use primers OE-htyF, EcoRⅤ-F / OE-htyF, EcoRⅤ-R, use the chassis strain A.pachycristatus NRRL 11440 genomic DNA as a template, and obtain the target gene fragment by PCR amplification. The amplification system and reaction procedure are the same as those in Example 2. This gene fragment contains the complete ORF region of the target gene from the start site to the end site. The amplified target gene sequence is purified and its concentration is determined. The size of the obtained fragment is determined by agarose gel electrophoresis.

[0123] ②Linearization of pBARGPE1-Hygro plasmid: Prepare EcoRV restriction enzyme system of pBARGPE1-Hygro plasmid, the total system is 10 μL, the specific preparation system is shown in Table 8 below, after mixing, the prepared restriction enzyme system is placed in a 37°C water bath and incubated for 3.5 hours; after the restriction enzyme cutting is completed, gel electrophoresis is performed to verify and the linearized pBARGPE1-Hygro plasmid is purified and recovered by gel tapping recovery and its concentration is determined.

[0124] Table 8 Enzyme Digestion Reaction System

[0125]

[0126] ③ Plasmid recombination construction: The target gene and the linearized pBARGPE1-Hygro plasmid were enzymatically connected using a recombinase (NoviZan). The total system was 10 μL. The specific preparation system was as shown in Table 9: (the molar amount of target gene fragment and linearized pBARGPE1-Hygro plasmid added (μg) = fragment length (bp) × 2%). After mixing the recombinase connection system, the prepared system was placed in a PCR instrument and incubated at 37°C for 30 min.

[0127] Table 9 Recombinase ligation reaction system

[0128]

[0129] ④ The ligated product was transferred to competent E. coli cells, and after screening and colony PCR verification, the verification primers were gpd-yan-F / OE-htyF, EcoRⅤ-R, and the primers were shown in Table 3). The correctly verified E. coli was cultured and the plasmid was extracted and sequenced to obtain the correctly sequenced htyF high-key plasmid (such as Figure 3 shown).

[0130] Example 4

[0131] Construction of high-yield strain LP-2 of echinocandin B

[0132] The htyF high-profile plasmid successfully constructed in Example 3 was transferred into the protoplasts of the chassis strain LP-1. The specific process was as follows: the htyF high-profile plasmid was mixed with the protoplasts of the chassis strain LP-1 and ice-bathed for 50 minutes. 10 μg of htyF high-profile plasmid was added to every 100 μL of protoplasts, followed by 1.25 mL of PEG and placed at room temperature for 25 minutes) (PEG: PEG 4000 60%, calcium chloride 2.35 g / L, Tris-HCl 50 mM, hydrochloric acid adjusted to pH 7.5, and sterilized at 115°C for 20 minutes). The correct colonies were screened out by hygromycin resistance plates, and the resistant strains were cultured in rich culture medium and then genomic DNA was extracted. The diagnostic PCR was used for verification, and the verification primers were gpd-yan-F / htyF-OE-yan-R. The primers are shown in Table 3. The specific diagnostic PCR system and reaction procedure implementation steps are the same as in Example 2, and the echinocandin B high-yielding strain LP-2 is obtained.

[0133] Example 5

[0134] Verification of Echinocandin B Fermentation of Genetically Engineered Strain LP-2

[0135] The genetically engineered strain LP-2 constructed by the present invention was subjected to seed culture and fermentation culture using the culture method described in the present invention to obtain a fermentation extract; the chassis strain A.pachycristatus NRRL 11440 was used as a comparison for fermentation culture, and the method was the same as that of the genetically engineered strain LP-2. After 48 hours of seed culture and 108 hours of fermentation culture, the fermentation yield of echinocandin B of the genetically engineered strain reached 366.5 mg / L, which was 110% higher than that of the chassis strain.

[0136] The present invention uses the echinocandin B producing strain A.pachycristatus NRRL 11440 as the chassis strain, verifies the function of htyF in the synthesis process of echinocandin B, and identifies the characteristics of the substrate NNU-1 of the HtyF catalytic reaction. It is found that under the LC-MS detection conditions of the present invention, the liquid phase detection retention time of NNU-1 is between 26.5 and 27.5 minutes, and the corresponding nucleus-to-cytoplasm ratio is M / Z=1044.3[M+H] + ; The present invention uses gene editing to transform, first by replacing the original promoter of the gene encoding the hexapeptide core synthetase of echinocandin B with the gpd constitutive strong promoter, so that the ecdA gene is highly expressed, the initial process of echinocandin B synthesis is promoted, and the synthesis and accumulation of echinocandin B and its precursor NNU-1 are strengthened. Then, LP-1 is used as the chassis strain to highly express the htyF gene in the genome, promote the oxidative modification and transformation of the echinocandin B precursor, further increase the biosynthesis of echinocandin B, and finally obtain the genetically engineered strain LP-2 with high yield of echinocandin B. The construction of this genetically engineered strain significantly improves the fermentation yield of echinocandin B. When the chassis strain is cultured in a liquid shake flask, the fermentation yield of echinocandin B is only 174.5 mg / L after 48 hours of seed culture and 108 hours of fermentation culture. When the genetically engineered strain LP-2 provided by the present invention is cultured in a liquid shake flask, the fermentation yield of echinocandin B is 366.5 mg / L by the same fermentation method. Figure 4 As shown, the genetically engineered strain LP-2 significantly improved the production of echinocandin B, and significantly exceeded the chassis strain and LP-1, and has potential industrial application value.

[0137] Comparative Example 1

[0138] The htyF high-profile plasmid successfully constructed in Example 3 was transferred into the protoplasts of the chassis strain A.pachycristatus NRRL11440. The specific process was as follows: the htyF high-profile plasmid with the chassis strain was mixed and ice-bathed for 50 minutes, followed by the addition of 1.25 mL of PEG and the mixture was placed at room temperature for 25 minutes (PEG: PEG 4000 60%, CaCl2 2.35 g / L, Tris-HCl 50 mM, hydrochloric acid (HCl) was used to adjust the pH to 7.5, and sterilized at 115°C for 20 minutes). The correct colonies were screened on a hygromycin resistance plate, and the resistant strains were cultured in a rich medium and then the genomic DNA was extracted. The diagnostic PCR was used for verification, and the verification primers used were gpd-yan-F / htyF-OE-yan-R. The primers are shown in Table 3. The specific diagnostic PCR system and reaction procedure were implemented in the same manner as in Example 2 to obtain the htyF high-profile strain LP-5.

[0139] The fermentation method and quantitative detection method of htyF high-profile strain LP-5 are the same as those in Example 5. The fermentation test results are as follows: Figure 5 , the production of echinocandin B in LP-5 of the htyF high-profile strain alone did not significantly increase compared with the chassis strain.

[0140] From the above, it can be seen that the fermentation yield of echinocandin B of the htyF high-profile strain alone is almost not improved compared with the wild-type strain, while the yields of echinocandin B and NNU-1 of the ecdA high-profile strain LP-1 are significantly increased compared with the chassis strain, and the fermentation yield of echinocandin B of the ecdA and htyF co-high-profile strain LP-2 is further significantly increased compared with the LP-1 strain and the chassis strain. It can be proved that the co-high profile of ecdA and htyF plays a synergistic role in the fermentation yield of echinocandin B.

Claims

1. A genetically engineered strain with high yield of echinocandin B, characterized in that: The engineered strain is obtained by using a strain having an echinocandin gene cluster as a base strain, and highly expressing the ecdA gene and / or the htyF gene in the base strain.

2. The genetically engineered strain for high production of echinocandin B according to claim 1, characterized in that: The sequences of the ecdA gene and htyF gene are JX421684.1 (41269-63178) and JX421685.1 (22453-25202), respectively.

3. The genetically engineered strain for high production of echinocandin B according to claim 1, characterized in that: The strain having the gene cluster for producing echinocandins preferably includes Aspergillus crassifolius.

4. A method for constructing a genetically engineered strain with high yield of echinocandin B according to claim 1, characterized in that: The steps include: (1) Designing primers based on the ecdA gene sequence, using the genomic DNA of the chassis bacteria as a template, and amplifying the left and right homologous arms by PCR; fusing the left and right arms with a fragment containing the gpdA promoter, and introducing the fusion into the protoplasts of the chassis bacteria to obtain strain LP-1; (2) Primers were designed based on the htyF gene sequence, and the genomic DNA of the chassis bacteria was used as a template to obtain the htyF gene by PCR amplification. After ligation with the vector, a high-expression htyF plasmid was obtained, which was then transferred into the protoplasts of strain LP-1 to obtain strain LP-2.

5. The construction method according to claim 4, characterized in that The primer sequences described in step (1) include ecdA-LF / ecdA-LR (SEQ ID NO.1-2) and ecdA-RF / ecdA-RR (SEQ ID NO.3-4): ecdA-LF TGTACTGTCTGTAGCGAGCA ecdA-LR TAATCAATTGCCCGTCTGTCAAGGTCATTCAAGAGTGAAAC ecdA-RF CATCCAAGAACCTTTAATCAATGGAACGGAAACGCGTATT ecdA-RR AGGATATTGGCCTGGAACTG.

6. The construction method according to claim 4, characterized in that In step (1), the native promoter of the gene is replaced with a constitutive strong promoter by homologous recombination, and the constitutive strong promoter is the gpdA (3-phosphoglyceraldehyde dehydrogenase) promoter.

7. The construction method according to claim 4, characterized in that The primer sequences described in step (2) include OE-htyF, EcoRⅤ-F and OE-htyF, EcoRⅤ-R (SEQ ID NO.5-6): OE-htyF,EcoRⅤ-F: GGCTGCAGGAATTCGATATCATGCTCGCTACAGACAGTAC OE-htyF,EcoRⅤ-R: GTATCGATAAGCTTGATATCCTAATTCTTTGTGGCCGATG.

8. The construction method according to claim 4, characterized in that The vector described in step (2) is a pBARGPE plasmid, and the htyF high-modulation plasmid comprises a constitutive strong promoter gpdA, an htyF gene, a terminator trpC and a resistance screening marker.

9. Use of the genetically engineered strain with high yield of echinocandin B according to claim 1 in producing echinocandin B.

10. Use of ecdA gene and / or htyF gene in regulating the production of echinocandin B in a strain having an echinocandin gene cluster.

Citation Information

Cited By

  • Engineering strain with high yield of echinocandin B as well as construction method and application of engineering strain

    CN121182853A